| LRSRX | VSIAX | LRSRX / VSIAX | |
| Total Expense Ratio | 1.46 | 0.07 | 2,086% |
| Annual Report Gross Expense Ratio | 1.46 | 0.07 | 2,086% |
| Fund Existence | 18 years | 14 years | - |
| Gain YTD | 6.599 | 6.559 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 384M | 59.8B | 1% |
| Annual Yield % from dividends | 0.14 | 1.85 | 8% |
| Returns for 1 year | -0.14 | 12.04 | -1% |
| Returns for 3 years | 7.26 | 29.92 | 24% |
| Returns for 5 years | -7.96 | 51.14 | -16% |
| Returns for 10 years | -24.37 | 162.42 | -15% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYCX | 14.37 | 0.48 | +3.46% |
| NYLI Candriam Emerging Markets Eq Cl C | |||
| EQIRX | 16.35 | 0.22 | +1.36% |
| Allspring Emerging Markets Eq Advtg R6 | |||
| FVDKX | 40.52 | N/A | N/A |
| Fidelity Value Discovery K | |||
| GSURX | 62.38 | -0.70 | -1.11% |
| Goldman Sachs US Equity Insights R | |||
| VPMAX | 194.37 | -2.54 | -1.29% |
| Vanguard PRIMECAP Adm | |||